Publications - 'P'
Publications 2001 - 2025 de 2458
| Titre | DOI |
|---|---|
|
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP) D. Vernerey; F. Huguet; A. Vienot; D. Goldstein; S. Paget-Bailly; J.L. Van Laethem; B. Glimelius; P. Artru; M.J. Moore; T. Andre; L. Mineur; B. Chibaudel; M. Benetkiewicz; C. Louvet; P. Hammel; F. Bonnetain 2016 |
10.1038/bjc.2016.212 |
|
Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using F-18-FDG PET in luminal HER2-negative breast cancer O. Humbert; A. Berriolo-Riedinger; A. Cochet; M. Gauthier; C. Charon-Barra; S. Guiu; I. Desmoulins; M. Toubeau; I. Dygai-Cochet; C. Coutant; P. Fumoleau; F. Brunotte 2014 |
10.1007/s00259-013-2616-3 |
|
Prognostic Relevance of CD200/Btla Deletions in Pediatric Precursor-B Cell Acute Lymphoblastic Leukemia Treated According to the EORTC-CLG 58951 Protocol F. Ghazavi; T. Lammens; E. Clappier; S. Suciu; A. Caye; S. Zegrari; M. Bakkus; N. Grardel; Y. Benoit; Y. Bertrand; O. Minckes; V. Costa; A. Ferster; F. Mazingue; G. Plat; E. Plouvier; M. Poiree; A. Uyttebroeck; J.Van der We Bosch; H. Helsmoortel; M. Meul; N. Van Roy; J. Philippe; F. Speleman; H. Cave; P. Van Vlierberghe; B. De Moerloose 2014 |
|
|
Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis D. Figarella-Branger; K. Mokhtari; C. Colin; E. Uro-Coste; A. Jouvet; C. Dehais; C. Carpentier; C. Villa; C.A. Maurage; S. Eimer; M. Polivka; J.M. Vignaud; A. Laquerriere; H. Sevestre; E. Lechapt-Zalcman; I. Quintin-Roue; M.H. Aubriot-Lorton; M.D. Diebold; G. Viennet; C. Adam; D. Loussouarn; S. Michalak; V. Rigau; A. Heitzmann; F. Vandenbos; F. Forest; D. Chiforeanu; M.C. Tortel; F. Labrousse; M.P. Chenard; A.Tuan Nguyen; P. Varlet; J.Louis Kemeny; P.M. Levillain; D. Cazals-Hatem; P. Richard; J.Y. Delattre; P.O.L.A. Network 2015 |
10.1111/bpa.12227 |
|
Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort O. Colussi; T. Voron; A. Pozet; P. Hammel; A. Sauvanet; J.B. Bachet; J.C. Vaillant; P. Rougier; B. Nordlinger; A. Berger; R. Coriat; B. Dousset; D. Malka; T. Andre; F. Paye; T. Aparicio; C. Locher; C. Zeleck; L. Tchinou; F. Bonnetain; J. Taieb 2015 |
10.1016/j.ejso.2015.01.010 |
|
Prognostic Significance of Arterial Lactate Levels at Weaning from Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation F. Biancari; A. Fiore; K. Jonsson; G. Gatti; S. Zipfel; V.G. Ruggieri; A. Perrotti; K. Bounader; A. Loforte; A. Lechiancole; D. Saeed; A. Lichtenberg; M. Pol; C. Spadaccio; M. Pettinari; K. Mogianos; K. Alkhamees; G. Mariscalco; Z.El Dean; N. Settembre; H. Welp; A.M. DellAquila; T. Fux; T. Juvonen; M. Dalen 2019 |
10.3390/jcm8122218 |
|
Prognostic significance of central venous-to-arterial carbon dioxide difference during the first 24 hours of septic shock in patients with and without impaired cardiac function G. Muller; E. Mercier; P. Vignon; M. Henry-Lagarrigue; T. Kamel; A. Desachy; V. Botoc; G. Plantefeve; J.P. Frat; F. Bellec; J.P. Quenot; F. Dequin; T. Boulain; C.Res Intens Sepsis 2017 |
10.1093/bja/aex131 |
|
Prognostic Significance of Concurrent Gene Mutations in Intensively Treated Patients with IDH1/2 Mutated AML M. Duchmann; J.B. Micol; N. Duployez; E. Raffoux; X. Thomas; J.P. Marolleau; T. Braun; L. Ades; S. Chantepie; E. Lemasle; C. Berthon; J.Valere Malfuson; C. Pautas; J. Lambert; N. Boissel; K. Celli-Lebras; D. Caillot; P. Turlure; N. Vey; A. Pigneux; C. Recher; C. Terre; C. Gardin; R. Itzykson; C. Preudhomme; H. Dombret; S. de Botton 2019 |
10.1182/blood-2019-127082 |
|
Prognostic significance of FDG-PET/CT derived parameters in a first metastatic breast cancer relapse E. Depardon; S. Kanoun; O. Humbert; J. Riedinger; I. Tal; J. Vrigneaud; M. Lasserre; M. Toubeau; A. Berriolo-Riedinger; I. Dygai-Cochet; P. Fumoleau; F. Brunotte; A. Cochet 2016 |
|
|
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial J. Taieb; V. Taly; J. Henriques; C. Bourreau; L. Mineur; J. Bennouna; J. Desrame; C. Louvet; C. Lepere; M. Mabro; J. Egreteau; O. Bouche; C. Mulot; K. Hormigos; K. Chaba; T. Mazard; A. de Gramont; D. Vernerey; T. Andre; P. Laurent-Puig 2021 |
10.1158/1078-0432.CCR-21-0271 |
|
PROGNOSTIC VALUE OF 18F-FLUORODEOXYGLUCOSE PET-CT SCORE AT BASELINE ON THE THERAPEUTIC RESPONSE TO PREDNISONE IN PATIENTS WITH POLYMYALGIA RHEUMATICA N. Giraud; M. Sondag; A. Charpentier; H. Boulahdour; C. Prati; D. Wendling; F. Verhoeven 2019 |
10.1136/annrheumdis-2019-eular.6192 |
|
Prognostic value of 18F-fluorodeoxyglucose PET-CT score at baseline on the therapeutic response to prednisone in patients with polymyalgia rheumatica N. Giraud; C. Prati; D. Wendling; F. Verhoeven 2021 |
10.1016/j.jbspin.2020.105093 |
|
Prognostic Value of a New Clinically-Based Classification System in Patients with CMML Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis of the EBMT Chronic Malignancies Working Party F. Onida; G. Sbianchi; L. Koster; S. Iacobelli; P. Dreger; M. Bornhaeuser; N. Kroeger; J. Sierra; G. Socie; J.J. Cornelissen; X. Poire; E. Faber; J.H. Bourhis; J. Finke; J.R. Passweg; U. Salmenniemi; H.C. Schouten; Y. Beguin; S. Martin; E. Deconinck; A. Ganser; S. Zver; B. Lioure; N.H. Russell; M. Robin; I. Yakoub-Agha 2018 |
10.1182/blood-2018-99-118490 |
|
PROGNOSTIC VALUE OF ACUTE KIDNEY INJURY AND HEMOCONCENTRATION DURING ACUTE HEART FAILURE Y. Lombardi; F. Boccara; K. Baldet; S. Ederhy; P. Nhan; Q. Riller; M. Chauvet-Droit; M.L. Jean; S. Adavane-Scheuble; L. Azoyan; A. Cohen 2020 |
|
|
Prognostic value of admission hyperglycaemia in black Africans with acute coronary syndromes: a cross-sectional study H. Yao; A. Ekou; T. Niamkey; C. Toure; C. Guenancia; I. Kouame; C. Gbassi; C. Konin; R. N'Guetta 2020 |
10.5830/CVJA-2020-028 |
|
Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers S. Guiu; C. Mollevi; C. Charon-Barra; F. Boissiere; E. Crapez; E. Chartron; P.J. Lamy; M. Gutowski; C. Bourgier; G. Romieu; J. Simony-Lafontaine; W. Jacot 2018 |
10.1038/s41416-018-0142-6 |
|
Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple-negative breast cancer S. Guiu; C. Charon-Barra; C. Mollevi; F. Boissiere; E. Crapez; E. Chartron; P.J. Lamy; M. Gutowski; C. Bourgier; G. Romieu; J. Simony-Lafontainc; W. Jacot 2017 |
10.1158/1538-7445.SABCS16-P3-05-06 |
|
Prognostic Value of Angiopoietin-2 for Death Risk Stratification in Patients with Metastatic Colorectal Carcinoma M. Jary; D. Vernerey; T. Lecomte; E. Dobi; F. Ghiringhelli; F. Monnien; Y. Godet; S. Kim; O. Bouche; S. Fratte; A. Goncalves; J. Leger; L. Queiroz; O. Adotevi; F. Bonnetain; C. Borg 2015 |
10.1158/1055-9965.EPI-14-1059 |
|
PROGNOSTIC VALUE OF ANGIOPOIETIN-2 FOR OVERALL SURVIVAL IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA TREATED BY CHEMOTHERAPY AND BEVACIZUMAB M. Jary; D. Vernerey; E. Dobi; F. Monnien; Y. Godet; S. Kim; O. Bouche; S. Fratte; F. Ghiringhelli; A. Goncalvez; T. Lecomte; J. Leger; L. Queiroz; O. Adotevi; F. Bonnetain; C. Borg 2014 |
|
|
PROGNOSTIC VALUE OF ANGIOPOIETIN-2 FOR OVERALL SURVIVAL IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA TREATED BY CHEMOTHERAPY AND BEVACIZUMAB M. Jary; D. Vernerey; E. Dobi; F. Monnien; Y. Godet; S. Kim; O. Bouche; S. Fratte; F. Ghiringhelli; A. Goncalvez; T. Lecomte; J. Leger; L. Queiroz; O. Adotevi; F. Bonnetain; C. Borg 2014 |
|
|
Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma M. Samimi; L. Molet; M. Fleury; H. Laude; A. Carlotti; C. Gardair; M. Baudin; L. Gouguet; E. Maubec; M. Avenel-Audran; E. Esteve; E. Wierzbicka-Hainaut; N. Beneton; F. Aubin; F. Rozenberg; N. Dupin; M.F. Avril; G. Lorette; S. Guyetant; P. Coursaget; A. Touze 2016 |
10.1111/bjd.14313 |
|
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial A.S. Cottereau; A. Versari; A. Loft; O. Casasnovas; M. Bellei; R. Ricci; S. Bardet; A. Castagnoli; P. Brice; J. Raemaekers; B. Deau; C. Fortpied; T. Raveloarivahy; E. Van Zele; L. Chartier; T.Vander Borght; M. Federico; M. Hutchings; U. Ricardi; M. Andre; M. Meignan 2018 |
10.1182/blood-2017-07-795476 |
|
Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial A.Segolene Cottereau; A. Versari; A. Loft; R.O. Casasnovas; M. Bellei; R. Ricci; S. Bardet; A. Castagnoli; P. Brice; J. Raemaeker; E. Itti; C. Forpied; T. Raveloarivahy; T. Girinsky; T. van der Borght; M. Federico; M. Hutchings; U. Ricardi; M. Meignan; M. Andre 2016 |
10.1182/blood.V128.22.184.184 |
|
Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score M. Jary; T. Lecomte; O. Bouche; S. Kim; E. Dobi; L. Queiroz; F. Ghiringhelli; H. Etienne; J. Leger; Y. Godet; J. Balland; Z. Lakkis; O. Adotevi; F. Bonnetain; C. Borg; D. Vernerey 2016 |
10.1002/ijc.30367 |
|
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL) A.S. Cottereau; S. Becker; F. Broussais; O. Casasnovas; S. Kanoun; M. Roques; N. Charrier; S. Bertrand; R. Delarue; C. Bonnet; R. Hustinx; P. Gaulard; L. De Leval; P. Vera; E. Itti; N. Mounier; C. Haioun; H. Tilly; M. Meignan 2016 |
10.1093/annonc/mdw011 |